Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation…
Unfinished Business on the Glass Ceiling
Reflecting on my career and the significant societal and technological shifts…
Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a…
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Be Bold, Be Empowered
Coming up the ranks in various roles, I remember feeling frustrated at times when leadership would not “decide” or “give direction.” We were all…
Optimize Your Congress Planning
Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a substantial opportunity and a…
Communicating Without a Communications Leader
Many of our clients are emerging companies striving towards their first clinical development program in anticipation of delivering on a promise to…
Forecasting Models: It’s Not All About the Numbers
What is the difference between strategic thinking in quantifying the future and Excel gymnastics? This was a distinction I needed to learn in my…
Appreciation for Interconnectedness
It was March 2020 when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that…
Finding Partners in Biopharma: Standing Out in a Field of Many
When biopharma executives or business development leaders think about developing their “partnering story,” the focus is often on the innovation.…
Gaining Participation in Clinical Trials
When it comes to patient recruitment and retention for clinical trials, the bottom line is simply this: It is important and challenging in all…
Reboot the “Get Organized” Ideas
Last week, The NemetzGroup team met (virtually, of course!) to share insights from 2021 and how we could make 2022 even better. We broke into small…
